vs
Brightstar Lottery PLC（BRSL）与汉瑞祥（HSIC）财务数据对比。点击上方公司名可切换其他公司
汉瑞祥的季度营收约是Brightstar Lottery PLC的1.4倍（$3.4B vs $2.5B），Brightstar Lottery PLC净利率更高（5.9% vs 2.9%，领先2.9%），汉瑞祥自由现金流更多（$338.0M vs $-415.0M）
汉瑞祥（Henry Schein, Inc.）是美国的医疗保健产品及服务分销商，业务覆盖全球33个国家和地区，是全球面向诊所类牙科及医疗从业者的最大医疗解决方案供应商。公司连续14年入选Ethisphere评选的「全球最具道德企业」榜单，2025年再次登榜。
BRSL vs HSIC — 直观对比
营收规模更大
HSIC
是对方的1.4倍
$2.5B
净利率更高
BRSL
高出2.9%
2.9%
自由现金流更多
HSIC
多$753.0M
$-415.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.5B | $3.4B |
| 净利润 | $147.0M | $101.0M |
| 毛利率 | — | 30.9% |
| 营业利润率 | 11.9% | 4.7% |
| 净利率 | 5.9% | 2.9% |
| 营收同比 | — | 7.7% |
| 净利润同比 | — | 7.4% |
| 每股收益（稀释后） | $0.74 | $0.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRSLHSIC
| Q4 25 | $2.5B | $3.4B | ||
| Q3 25 | — | $3.3B | ||
| Q2 25 | — | $3.2B | ||
| Q1 25 | — | $3.2B | ||
| Q4 24 | — | $3.2B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | — | $3.1B | ||
| Q1 24 | — | $3.2B |
净利润BRSLHSIC
| Q4 25 | $147.0M | $101.0M | ||
| Q3 25 | — | $101.0M | ||
| Q2 25 | — | $86.0M | ||
| Q1 25 | — | $110.0M | ||
| Q4 24 | — | $94.0M | ||
| Q3 24 | — | $99.0M | ||
| Q2 24 | — | $104.0M | ||
| Q1 24 | — | $93.0M |
毛利率BRSLHSIC
| Q4 25 | — | 30.9% | ||
| Q3 25 | — | 30.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 31.6% | ||
| Q4 24 | — | 31.1% | ||
| Q3 24 | — | 31.3% | ||
| Q2 24 | — | 32.5% | ||
| Q1 24 | — | 31.9% |
营业利润率BRSLHSIC
| Q4 25 | 11.9% | 4.7% | ||
| Q3 25 | — | 4.9% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | 5.5% | ||
| Q4 24 | — | 4.9% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 4.7% |
净利率BRSLHSIC
| Q4 25 | 5.9% | 2.9% | ||
| Q3 25 | — | 3.0% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 3.1% | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | 2.9% |
每股收益（稀释后）BRSLHSIC
| Q4 25 | $0.74 | $0.85 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | — | $0.70 | ||
| Q1 25 | — | $0.88 | ||
| Q4 24 | — | $0.75 | ||
| Q3 24 | — | $0.78 | ||
| Q2 24 | — | $0.80 | ||
| Q1 24 | — | $0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $156.0M |
| 总债务越低越好 | $4.1B | $2.3B |
| 股东权益账面价值 | $875.0M | $3.2B |
| 总资产 | $9.2B | $11.2B |
| 负债/权益比越低杠杆越低 | 4.64× | 0.71× |
8季度趋势，按日历期对齐
现金及短期投资BRSLHSIC
| Q4 25 | $1.4B | $156.0M | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | $145.0M | ||
| Q1 25 | — | $127.0M | ||
| Q4 24 | — | $122.0M | ||
| Q3 24 | — | $126.0M | ||
| Q2 24 | — | $138.0M | ||
| Q1 24 | — | $159.0M |
总债务BRSLHSIC
| Q4 25 | $4.1B | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $1.9B | ||
| Q1 24 | — | $2.0B |
股东权益BRSLHSIC
| Q4 25 | $875.0M | $3.2B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | — | $3.4B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | — | $3.4B | ||
| Q3 24 | — | $3.5B | ||
| Q2 24 | — | $3.5B | ||
| Q1 24 | — | $3.6B |
总资产BRSLHSIC
| Q4 25 | $9.2B | $11.2B | ||
| Q3 25 | — | $11.1B | ||
| Q2 25 | — | $10.9B | ||
| Q1 25 | — | $10.5B | ||
| Q4 24 | — | $10.2B | ||
| Q3 24 | — | $10.6B | ||
| Q2 24 | — | $10.3B | ||
| Q1 24 | — | $10.1B |
负债/权益比BRSLHSIC
| Q4 25 | 4.64× | 0.71× | ||
| Q3 25 | — | 0.64× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | — | 0.54× | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | 0.56× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-99.0M | $381.0M |
| 自由现金流经营现金流 - 资本支出 | $-415.0M | $338.0M |
| 自由现金流率自由现金流/营收 | -16.5% | 9.8% |
| 资本支出强度资本支出/营收 | 12.6% | 1.3% |
| 现金转化率经营现金流/净利润 | -0.67× | 3.77× |
| 过去12个月自由现金流最近4个季度 | — | $573.0M |
8季度趋势，按日历期对齐
经营现金流BRSLHSIC
| Q4 25 | $-99.0M | $381.0M | ||
| Q3 25 | — | $174.0M | ||
| Q2 25 | — | $120.0M | ||
| Q1 25 | — | $37.0M | ||
| Q4 24 | — | $204.0M | ||
| Q3 24 | — | $151.0M | ||
| Q2 24 | — | $296.0M | ||
| Q1 24 | — | $197.0M |
自由现金流BRSLHSIC
| Q4 25 | $-415.0M | $338.0M | ||
| Q3 25 | — | $141.0M | ||
| Q2 25 | — | $88.0M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $168.0M | ||
| Q3 24 | — | $117.0M | ||
| Q2 24 | — | $259.0M | ||
| Q1 24 | — | $156.0M |
自由现金流率BRSLHSIC
| Q4 25 | -16.5% | 9.8% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | — | 4.9% |
资本支出强度BRSLHSIC
| Q4 25 | 12.6% | 1.3% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 1.3% |
现金转化率BRSLHSIC
| Q4 25 | -0.67× | 3.77× | ||
| Q3 25 | — | 1.72× | ||
| Q2 25 | — | 1.40× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 2.17× | ||
| Q3 24 | — | 1.53× | ||
| Q2 24 | — | 2.85× | ||
| Q1 24 | — | 2.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRSL
暂无分部数据
HSIC
| Global Dental Merchandise | $1.2B | 35% |
| Global Medical | $1.1B | 31% |
| Global Dental Equipment | $536.0M | 16% |
| Global Specialty Products | $422.0M | 12% |
| Global Technology | $173.0M | 5% |
| Global Value Added Services | $64.0M | 2% |
| Equity Method Investee | $14.0M | 0% |
